Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Latin America
6.2 Regional
7 Opportunities and Challenges in the Market
8 Latin America Plasma Fractionation Market Analysis
8.1 Key Industry Highlights
8.2 Latin America Plasma Fractionation Historical Market (2019-2025)
8.3 Latin America Plasma Fractionation Market Forecast (2026-2035)
8.4 Latin America Plasma Fractionation Market by Product
8.4.1 Immunoglobulins
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2019-2025)
8.4.1.3 Forecast Trend (2026-2035)
8.4.2 Coagulation Factor Concentrates
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2019-2025)
8.4.2.3 Forecast Trend (2026-2035)
8.4.3 Albumin
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2019-2025)
8.4.3.3 Forecast Trend (2026-2035)
8.4.4 Protease Inhibitors
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2019-2025)
8.4.4.3 Forecast Trend (2026-2035)
8.4.5 Others
8.5 Latin America Plasma Fractionation Market by Application
8.5.1 Neurology
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2019-2025)
8.5.1.3 Forecast Trend (2026-2035)
8.5.2 Immunology
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2019-2025)
8.5.2.3 Forecast Trend (2026-2035)
8.5.3 Hematology
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2019-2025)
8.5.3.3 Forecast Trend (2026-2035)
8.5.4 Rheumatology
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2019-2025)
8.5.4.3 Forecast Trend (2026-2035)
8.5.5 Others
8.6 Latin America Plasma Fractionation Market by Processing Technology
8.6.1 Ion- Exchange Chromatography
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2019-2025)
8.6.1.3 Forecast Trend (2026-2035)
8.6.2 Affinity Chromatography
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2019-2025)
8.6.2.3 Forecast Trend (2026-2035)
8.6.3 Cryopreservation
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2019-2025)
8.6.3.3 Forecast Trend (2026-2035)
8.6.4 Ultrafiltration
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2019-2025)
8.6.4.3 Forecast Trend (2026-2035)
8.6.5 Microfiltration
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2019-2025)
8.6.5.3 Forecast Trend (2026-2035)
8.7 Latin America Plasma Fractionation Market by End Use
8.7.1 Hospitals and Clinics
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2019-2025)
8.7.1.3 Forecast Trend (2026-2035)
8.7.2 Clinical Research Laboratories
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2019-2025)
8.7.2.3 Forecast Trend (2026-2035)
8.7.3 Academic Institutes
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2019-2025)
8.7.3.3 Forecast Trend (2026-2035)
8.7.4 Others
8.8 Latin America Plasma Fractionation Market by Country
8.8.1 Market Share
8.8.1.1 Brazil
8.8.1.2 Argentina
8.8.1.3 Mexico
8.8.1.4 Others
9 Regional Analysis
9.1 Brazil
9.1.1 Historical Trend (2019-2025)
9.1.2 Forecast Trend (2026-2035)
9.2 Argentina
9.2.1 Historical Trend (2019-2025)
9.2.2 Forecast Trend (2026-2035)
9.3 Mexico
9.3.1 Historical Trend (2019-2025)
9.3.2 Forecast Trend (2026-2035)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Powers
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 CSL Plasma LLC
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Grifols, S.A.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Takeda Pharmaceutical Company Limited
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Biotest Group
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Baxter International Inc.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Industry Events and Developments